UPDATE : Monday, October 15, 2018
상단여백
Sanofi-Aventis Korea unveils sub-analysis for dyslipidemia therapy
Sanofi-Aventis Korea said Friday that it has published the results of ODYSS...
by Lee Han-soo  |  2018-10-12 17:25
라인
Abbvie’s hepatitis C drug expands indication
Abbvie’s Maviret, a hepatitis C treatment, has received approval for additi...
by Lee Han-soo  |  2018-10-12 15:40
라인
Bridge Bio completes phase-1 study for ulcerative colitis drug in US
Bridge Biotherapeutics said Friday that it has completed phase-1 clinical t...
by Lee Han-soo  |  2018-10-12 13:38
라인
Boryung to export anticancer drugs to Philippine
Boryung Pharmaceutical said Friday that it has signed a deal with Endure Me...
by Lee Han-soo  |  2018-10-12 13:26
라인
‘Korea’s treatment guidelines for multidrug-resistant TB outdated’
South Korea’s guidelines for the treatment of multidrug-resistant tuberculo...
by Choi Gwang-seok  |  2018-10-12 11:12
라인
SNUH to research birth cohort related to environmentally hazardous substances
Seoul National University Hospital (SNUH) said a team at its Institute of E...
by Lee Han-soo  |  2018-10-11 17:24
라인
[News Focus] Authorities close in on drug firm owners in bribery case
The issue of illegal rebates is stirring the Korean pharmaceutical sector, ...
by So Jae-hyeon  |  2018-10-11 16:33
라인
Merck to supply Samsung’s biosimilar to US Veterans Affairs Dept.
Merck, known as MSD outside the United States and Canada, announced that is...
by Lee Han-soo  |  2018-10-11 16:31
라인
Endoscopic surgery reduces operation time for auditory neoplasm
Researchers at Severance Hospital have discovered that endoscopic surgery c...
by Lee Han-soo  |  2018-10-11 15:13
라인
YD Life Science wins source tech for anti-cancer gene therapy
YD Life Science said Wednesday that it has signed a technology transfer agr...
by Lee Han-soo  |  2018-10-11 14:46
라인
BMS to test cabiralizumab+nivolumab for pancreatic cancer
Bristol-Myers Squibb is soon to conduct phase-2 trials in Korea on its immu...
by Lee Hye-seon  |  2018-10-11 14:23
라인
US drug advisory recommends Celltrion’s Rituxan biosimilar for approval
Celltrion said Thursday that the U.S. Oncologic Drug Advisory Committee (OD...
by Lee Han-soo  |  2018-10-11 12:10
라인
Anticipation grows for Lenvima as new liver cancer drug
Eisai Korea’s Lenvima (lenvatinib), recently approved as a first-line treat...
by Nam Doo-hyun  |  2018-10-11 11:44
라인
Patient group calls for government steps to eliminate ghost surgery
The Korea Alliance of Patients Organizations (KAPO) Wednesday urged the gov...
by Lee Han-soo  |  2018-10-10 18:21
라인
‘Korea publishes many biotech papers but rarely links them to biz’
South Korea’s ranking in biotech competitiveness, announced by the U.S. sci...
by Nam Doo-hyun  |  2018-10-10 16:35
라인
St. Mary’s Hospital develops method to fight intractable blood disease
Researchers at St. Mary’s Hospital have discovered a method that can drasti...
by Lee Han-soo  |  2018-10-10 16:33
라인
Kukje Pharm CEO, executives booked for bribing doctors
A midsize Korean pharmaceutical company has been embroiled in an illegal re...
by So Jae-hyeon  |  2018-10-10 15:31
라인
Rayence sets up industry-academia research center with Yonsei University
Rayence said Wednesday that it has signed a joint research agreement with Y...
by Lee Han-soo  |  2018-10-10 15:30
라인
Physicians to root out ghost surgeries
Under severe criticism for a recent series of ghost surgeries, the medical ...
by Choi Gwang-seok  |  2018-10-10 13:48
라인
Hanmi unveils test results for asthma-rhinitis combination drug in US
Hanmi said Wednesday that it has presented its phase 3 clinical trial resul...
by Lee Han-soo  |  2018-10-10 12:08
여백
여백
여백
Back to Top